Straumann stock slips as market cap sits at $20.24 billion

Straumann Holding AG (CH0012280076) stock is priced at $127.24, down 1.63 percent, with a market cap of $20.24 billion and 202 shares traded in the latest snapshot from August 7, 2026.

Valuation stays tight

The same market snapshot puts the 50-day range at $117.24 to $135.00 and the 52-week range at $93.18 to $135.00. That leaves the shares trading 5.7 percent below the top of the 52-week band and 3.2 percent above the 50-day low.

MarketBeat's earnings page points to August 19, 2026 as the next reporting date, with consensus EPS at $1.97 and expected revenue at $1.70 billion.

What the next report matters for

For investors, the key comparison is whether Straumann can turn that $1.70 billion revenue expectation into another step up from the prior period. The market already has a narrow range in view, and the shares are only 5.7 percent below the 52-week high.

A second data point is the current valuation backdrop: the same quote page shows a price-to-cash-flow ratio of 41.32 and a free float of 159.1 million shares.

Product and business mix

Straumann's restorative and regenerative dentistry portfolio spans implants, prosthetics, biomaterials, digital solutions, and orthodontics. That mix is the operating base behind the company's reported market value and the earnings setup into August 19, 2026.

Straumann stock closed the latest cited snapshot at $127.24, and the market cap stood at $20.24 billion on August 7, 2026.

Fact box

Company: Straumann Holding AG
ISIN: CH0012280076
Ticker: SAUHF
Exchange: OTCMKTS
Price (as of August 7, 2026, 3:46 p.m. ET): $127.24 USD
Market cap: $20.24 billion
Sector / Industry: Health Care / Medical Instruments & Supplies
Next earnings date: August 19, 2026